SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " medication " 386 found 🔀 AI-powered Shuffle
GLP-1 drugs may protect kidney health in people with bipolar disorder
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Novant Health to host drive-thru medicine take-back
Residents can drop off unused medications, syringes and vaping devices for free Saturday at Novant Health’s drive-thru collection event.
Six Penn State Health locations to offer safe medication disposal on National Prescription Drug Take-Back Day
As part of a nationwide drug take-back effort, Penn State Health and local police departments will offer medication disposal sites across central Pennsylvania on Saturday, Oct. 24.
Essentia Health hosting Hypertension Night
There, attendees can get their blood pressure checked, receive educational materials, have experts review your medications and have an at-home blood pressure cuff calibrated.
Novant Health to host drive-thru medicine take-back
Residents can drop off unused medications, syringes and vaping devices for free Saturday at Novant Health’s drive-thru collection event.
Naples Comprehensive Health Collaborates with Publix Pharmacy to Launch Meds-to-Beds Service - Florida Hospital News and Healthcare Report
New service will deliver discharge prescriptions directly to patients at the hospital, helping support medication access and continuity of care October 19, 2026 – Naples Comprehensive Health (NCH) is collaborating […]
Why police arrive at this Arizona behavioral health facility almost daily
Recent reports of medication theft and assaults at a behavioral health center in Chandler add to an ongoing list of problems involving young patients at the facility, including allegations of rape, theft, runaways, and criminal property damage.
Gateway Health Alliances to discuss GLP-1 product innovation at SupplySide Global
The US botanical ingredient supplier will be exploring weight management, metabolic health and nutritional support for consumers discontinuing GLP-1 medications at this year's show
Gut Microbiome and Aging: How Gut Bacteria Influence Health and Longevity
The gut microbiome changes with age, with microbial diversity and function varying according to health status, diet, lifestyle, and medication use. These changes are associated with inflammation and age-related diseases, but evidence that microbiome-targeted interventions extend human lifespan remains limited.
‘A real-world story’: Ruidoso doctor pens novel on youth mental health
The novel introduces young readers to a 13-year-old who attends therapy and is prescribed medication for anger management.
Exclusive-US Strikes One-Year Deal to Fund Maternal and Newborn Health Donations in Poorest Countries
By Ammu Kannampilly, Jennifer Rigby and Victoire Mukenge NAIROBI/LONDON/NYANGEZI, Democratic Republic of Congo, Oct 16 (Reuters) - The US government has struck a deal to continue supplying some of the world's poorest nations with free life-saving medication and equipment for mothers, infants and ...
Can AI solve our mental health access problem?
Last week I asked you what worries you most about AI in health. It was close, but your top answer was “AI giving bad health advice.” Last week’s poll results: You’re in good company. This concern was top of mind at a conference I joined at Stanford last week, where researchers, clinicians, and people who build AI systems spent a day debating trust and safety in health AI. Stepping back, I’m also hearing your emerging concerns about AI’s impact on our well-being generally. I see this as a matter of public health, and we’ll take it in pieces as we learn together. Today we’ll focus on AI chatbots used for therapy for mental health. Early this month, Governor Newsom vetoed Senate Bill 903, California’s most ambitious attempt to regulate AI use for mental health. It’s at the center of active debate, and raises the questions patients, family members, citizens, and voters will face as AI moves deeper into health care. Let’s work through it. What is “AI-based therapy”? It’s really two things: purpose-built mental health apps designed to deliver structured support, and general chatbots like ChatGPT, Claude, and Gemini that people increasingly use for emotional support—even if they weren’t built for it. Spoiler alert: I don’t know whether the shift toward AI therapy is good or bad. The evidence isn’t there yet. But I do know it’s already happening, and I have some ideas about how we can roll it out with safety in mind. The therapy dilemma, in a nutshell Mental health challenges are common, and strain health and well-being across populations. Therapy (interactive dialogue with a trained, empathetic practitioner) helps many people heal. The demand for licensed therapists far exceeds the supply in California, and AI-based therapy can narrow that gap. AI-based therapy remains novel, unproven, and not well tested. Right off the bat, we can see we’re dealing with trade-offs here. Since the main driver of demand for therapy from a robot is lack of access to therapy from a human, we’ll start there. It’s too hard to find and afford a human therapist California is short roughly 55,000 licensed, non-prescribing therapists and counselors, about 40% of what we need. Psychiatrists, who rely on talk therapy as a complement to prescribed medications, are even more scarce. Eight counties have none, and density ranges from 1.7 per 100,000 residents in San Benito County, to 68.1 in Marin County. My wife is a psychiatrist in Marin, and even here access is tight. If it’s hard in the best-supplied county, imagine rural Sierra County, or the San Joaquin Valley. In 2024, more than half of Californians who tried to make a mental health appointment struggled to find a provider who took their insurance, compared with 14% for physical health care. When Senate staff posed as “secret shopper” patients and called 120 mental health providers in Medicare Advantage networks, they landed an appointment less than once for every five tries. Insurers pay behavioral health clinicians about 22% less than medical and surgical clinicians for comparable office visits. On top of that, billing denials and prior authorizations hit hardest at the solo and small practices common in mental health. Psychiatrists opt out of Medicare at the highest rate of any specialty. In many places, a cash practice for therapy fills quickly with patients paying $250 or more an hour, with no insurance paperwork at all. Families who can pay cash find providers more easily. Those who rely on insurance, including Medi-Cal enrollees, older adults, rural residents, and non-English speakers, compete for what’s left. So we can’t pretend the human system works, and we can’t blame people for turning to AI for support when they’re in distress. AI is filling the gap It’s estimated that roughly a quarter of AI users use it for mental health support. If you have internet, it’s available 24/7, it’s cheap, and it speaks your language. Uninsured adults are about twice as likely as insured adults to do it (30% vs. 14%). It feels anonymous in ways that may enable people to ask things they’re unsure or embarrassed about. The largely hidden, personal use makes it hard to study whether it’s actually helping people with their mental health issues, but researchers are trying. Does AI therapy work? A 2026 analysis of nearly 40 randomized trials found chatbots showed a real but small reduction in depression symptoms. But most of these trials were compared to an alternative of no therapy, not a human therapist. So the benefit of AI therapy is probably real, but modest, and mostly untested against the alternative of human contact. We need more studies. Serious concerns OpenAI’s own estimate is that more than a million ChatGPT users each week show signs of suicidal planning or intent. These are high stakes encounters, and AI doesn’t always get it right. That’s partly because a chatbot can sound like a therapist, but it has no license, no duty of care, and it’s not clear who to hold accountable when it gets things wrong. AI is also designed to help users in whatever task they’re seeking to accomplish. People may feel like they’re getting therapy, but they’re mainly getting a convincing conversation. It’s easy for an AI companion to wander into gray areas, like playing along with “creative writing” that may be about the user’s own suicidal intent. Courts are driving safety conversations A wave of lawsuits have been filed on behalf of families claiming that chatbots pushed people they loved toward self-harm, including teens who died by suicide. The first settlements came this year. OpenAI is headquartered in San Francisco, and dozens of cases alleging that ChatGPT drove users to suicide or self-harm are now before a San Francisco judge. Character.ai has filed for bankruptcy after several states brought lawsuits accusing the chatbot of pushing dangerous content to kids. But the technology seems to be improving. Last month, an independent evaluation found that newer AI models “almost never endorse suicide.” That’s progress, but our societal appetite for even one preventable death is very low. So how do we move forward? Finding a middle ground Earlier this month the governor vetoed Senate Bill 903, a bill designed to place guardrails on the use of AI for therapy. The bill would have prohibited any AI-based platform from being advertised as psychotherapy, and would have required a licensed professional to review and approve each encounter where AI was used to support therapeutic decisions. Newsom called it overly broad, since even routine screening questions would have needed clinician sign-off. Knowing we’re already short on mental health providers, requiring human review of AI encounters may not relieve our access problems. Still, the answer isn’t no oversight. Here’s one feasible short term solution. Rather than reviewing each encounter, a licensed clinician can design the guardrails: what counts as a crisis, what triggers an immediate handoff to a human, and what gets sampled for audit each month. The AI runs inside that structure. Conversations get checked, failures get reported, and a real clinician owns the framework. Medicine already has models to learn from. The FDA process for rolling out newly approved medications is an example. After a product reaches patients, we keep watching for adverse events. Patient-facing AI needs the same “digital pharmacovigilance”: systematic tracking of harms, near misses, and the types of groups that get hurt and why. It’s also critical that users know that they can reach a human if they’re in crisis. Most chatbots now include messages like these: Bottom line The rush to use unproven AI tools for mental health support is mostly a workaround, a sign of a health system people can’t get into. We need better access to proven care from licensed clinicians. That takes reimbursement that makes accepting insurance viable, and a bigger workforce. But, built and tested well, AI could be part of the answer. It could be the 2 a.m. check-in when no one else is awake, or a way for patients to practice skills their therapist taught them. It could be the first step to get someone the right level of care, and take paperwork off clinicians’ plates so they spend more time with patients. None of this is simple. The SB 903 veto doesn’t end the debate, and the legislature will be back. In the meantime, those of us using these tools need to stay informed, ask hard questions, and hold the companies building them accountable. I’ll try to do my part, and we’ll keep learning together. Love,Matt P.S. If you or someone you know is struggling with mental health challenges, emotional distress, substance use problems, or just needs to talk, call or text 988- you’ll reach a real person— or chat at 988lifeline.org 24/7. Dr. Matt Willis is the author of Your Local Epidemiologist in California. A California native, he’s served as a primary care physician, CDC epidemiologist, and public health officer for Marin County, where he guided the pandemic response. He lives in Marin with his family and their dogs, Teddy and Ramona. Thank you Cynthia He, MD, PhD, and Parnika Saxena, MD, for their guidance in preparing this article. Cynthia works in an outpatient mental health clinic, treating patients who have Medi-Cal or, sometimes, no insurance. Parnika works in an inpatient psychiatric unit, treating patients with public or private insurance or self-pay ability. All opinions are their own and do not represent their employers.
AI study of 101,000 patients links brown fat to heart and mental health
In a retrospective analysis of PET-CT records from 101,243 patients, researchers found that detectable brown fat was associated with lower prevalence of cardiometabolic and psychiatric conditions, while greater activity, particularly in the axillary region, was linked to more favourable metabolic outcomes. Medication screening identified losartan, which increased brown fat thermogenic activity in laboratory experiments and energy expenditure in mice, although its effects on human brown fat remain unproven.
C-U Public Health: The switch to generic naloxone will increase access to the lifesaving medication
Naloxone reverses opioid overdoses and is supplied to communities across Illinois thanks to federal funding. Health officials say the switch to a generic form will save money and increase the supply of the lifesaving medication across the state.
Weight-loss drugs may fight 7 serious health problems before the pounds even come off
GLP-1 medications like semaglutide and tirzepatide are repairing joints, calming inflammation, and protecting vital organs before any weight loss occurs.
New Intermountain Health Study Finds Escalating Treatment Earlier for Patients with Life-Threatening Septic Shock Doesn’t Improve Survival or Recovery
A new study from researchers at Intermountain Health in Salt Lake City found that starting an advanced medication earlier for critically ill patients with life-threatening septic shock does not improve their survival, shorten hospital stays, or improve their recovery compared with waiting until their condition potentially worsens.These new resea...
FAA Unveils New Tool to Gauge Fitness to Fly
MedGuide is an online, interactive resource that enables users to search medical conditions, prescriptions drugs and over-the-counter medications to determine whether a medication is acceptable for safety-related duties and whether an initial or subsequent-dose waiting period applies.
Elevance Health Foundation launched a prize program for patient safety initiatives. Here's why
The Elevance Health Foundation has launched a new prize program aimed at supporting solutions aimed at improving patient safety, with the first crop of winners targeting challenges like health lite | The Elevance Health Foundation has launched a new prize program aimed at supporting solutions aimed at improving patient safety, with the first crop of winners targeting challenges like health literacy, fall prevention and medication errors.
Ozempic and Wegovy linked to rare risk of sudden vision loss
Popular diabetes and weight loss drugs such as Ozempic and Wegovy have been linked to a slightly increased risk of a rare condition that can cause sudden, potentially permanent vision loss. Although the risk remains very low, Rutgers researchers say the findings warrant attention as millions of people turn to GLP-1 medications.
Governor, health advocates push bill to lower drug prices for 23 medications
Under the proposed legislation, the state's Prescription Drug Affordability Board would have the authority to match the maximum fair price for prescriptions negotiated by the federal Medicare program.
HOMETOWN HEALTH: Managing high blood pressure could save half a million lives worldwide, health experts say
Researchers recommend expanding treatment for high blood pressure and expanding access to cholesterol-lowering statin medications.
GLP-1 Users Face a Health-or-Wealth Choice
51% of GLP-1 users worry they may have to choose between medication and retirement savings. See what The Harris Poll found for Nationwide.
Selma Blair pleads not guilty and is released on bond after lawyers claim she didn’t take her medication before plane incident
The actress faces up to seven years behind bars.
Dear Abby: Ready to move despite mental health struggles
I think if I have a plan in place and stay on track with medication, it would be safe.
PLANNING AHEAD: What ‘It’s Possible’ means for health care
When it comes to health care, it can be difficult to determine whether “it’s possible” that some condition, treatment, medication, hospitalization or rehab is covered, for how much, or not.
The Watch: U.S. Pharmacy Closures Are Deepening Inequities
Millions of Americans are left without access to prescription medications … Military and outdoor workers face the highest rates of death from heat … and more.
Health expert shares simple ways to help lower inflammation throughout the body
Clinical pharmacist Jim LaValle breaks down how diet, stress, medications, blood sugar, environmental exposures and even overtraining may contribute to inflammation — and why the gut-brain connection matters.
A surprisingly simple way to relieve knee arthritis pain without pills or surgery
A surprisingly simple change in how you walk could help relieve knee arthritis pain and even slow joint damage. In a year-long clinical trial, researchers found that adjusting the angle of a person's foot while walking reduced osteoarthritis pain by an amount comparable to medication, without requiring drugs or surgery. Even more promising, MRI scans revealed that participants who adopted the personalized walking technique experienced slower deterioration in a marker of knee cartilage health.
We’re Investigating Prior Authorization. Help ProPublica Understand Your Health Insurance Denial.
ProPublica is looking into the ways health insurers’ use of prior authorization impacts patients. We need your help to figure out if the process is still leading to delayed or missed treatments, tests, medical equipment or medication.
Getting health advice online? A study suggests you may be getting a sales pitch
Pew Research Center found 38% of health influencer posts promoted products, services or subscriptions, with promotions appearing in about two-thirds of posts about supplements and over-the-counter medications.
People on weight-loss drugs report fingernails falling off as researchers uncover surprising link
Nail discoloration was reported by 46% of GLP-1 users versus 17% of non-users, while scalp inflammation accompanied hair loss in most medication users studied.
Utah approves slew of health AI pilots for drug management, women’s health
The state has expanded its controversial healthcare AI program with three new pilots that could ultimately see the technology provide care plans and medications without human review.
Study: How GLP-1 meds used to treat sleep apnea may affect oral health
“We need to understand how these medications affect the mouth so we can identify potential problems early and make sure patients receive comprehensive care.”
Doctors Should Keep an Eye on Your Mix of Medication. If They Don’t, You Should.
By Paula Span | KFF Health News Medications can snowball as we age. Pill organizers pile up. Prescriptions that are no longer necessary can mix with other drugs to create concerning side effects. “Once you get to six or seven prescription medications, you get a nearly 100% chance of some sort of ...
More than a prescription: Removing barriers so patients can get back to living
See how integrated specialty pharmacy support helped one patient overcome treatment barriers and get back to the moments that matter most.
The science behind targeted oral peptides
A new type of medication is tackling a problem that has long frustrated drug developers: how to deliver peptide therapies orally and hit their target more precisely.
Yale School of Medicine On the Science of Childhood Anxiety, Say, Anxiety Disorders Are the Most Common Mental Health Challenges In Youth
Credit: Matt Bradbury October 5, 2026 - By Isabella Backman - Anxiety disorders are the most common mental health challenges in youth. Left untreated, they can disrupt the lives of both children and their families. The good news is that with intervention, most children will overcome these conditions. Across Yale School of Medicine, scientists are working to understand anxiety at every level, from common anxious behaviors to molecular biomarkers in the brain. They are using their findings to develop and disseminate new evidence-based treatments for childhood anxiety. Today, the go-to treatment for childhood anxiety disorders is cognitive behavioral therapy (CBT). This is a form of psychotherapy that teaches children skills for confronting anxious thoughts and helps them practice managing situations that cause anxiety. While it is the gold-standard treatment backed by considerable scientific evidence, up to 50% of children will not see sufficient benefit from CBT alone. Wendy Silverman, PhD, Alfred A. Messer Professor in the Child Study Center, co-directs the Anxiety and Mood Disorders Program alongside Eli Lebowitz, PhD, associate professor in the Child Study Center. One of their main interests is learning how to improve outcomes beyond CBT. “We’re developing cutting-edge, research-based knowledge that can reduce the suffering that anxiety causes children and their families,” says Silverman. Changing parent behavior YSM experts are investigating how to improve CBT outcomes for children by involving the parents. Silverman’s research has uncovered two main components of parent intervention that improve childhood anxiety: not enabling children to completely avoid the things that make them anxious and taking steps to enhance their autonomy. Parents may unintentionally reinforce their child’s anxiety by allowing them to avoid what makes them anxious. They also may unintentionally limit the children’s sense of autonomy by being overly intrusive. “One of the things that we take pride in is that we’ve focused on trying to understand what parents need to do, and to test our ideas and see if changing the parents’ behaviors is enhancing the effects of CBT,” Silverman says. “Our findings thus far suggest that they do." As much as CBT can be helpful, it can also be challenging to get one’s child to do the necessary steps for CBT to work. This is one important reason why Lebowitz created a novel intervention program for parents named Supportive Parenting for Anxious Childhood Emotions (SPACE). Existing intervention programs often teach parents to act as therapists for their child, such as training them on how to practice breathing exercises. “It makes sense, but this doesn’t work very well in practice,” says Lebowitz. “And part of the reason, I think, is that it’s not easy to get your kid to do things, especially if they’re not excited about doing it.” SPACE is unique because it focuses entirely on parent involvement and changing parental behavior—children are not involved in the sessions. For example, parents learn how to use supportive messages that convey confidence that their child can tolerate and manage distress. “It might sound like a parent saying to a child, ‘I get that this is really hard for you, but I know that you can handle it,’” Lebowitz says. The program also works with parents to identify the ways in which they are accommodating anxious behaviors. “We’ll pick one thing that parents are doing that is an accommodation and help them make a detailed plan for how they’re going to change that,” Lebowitz explains. Treating Anxiety in Children and Adolescents Much of the existing research on SPACE has focused on parents of children under age 14. Ongoing studies are now exploring its use with parents of older teens. “Both anxiety and accommodation can interfere with normative developmental shifts during the teen years, including increased autonomy and individuation from parents,” says Rebecca Etkin, PhD, associate research scientist in the Child Study Center. “In this sense, SPACE may be particularly well-suited for anxious teens and their parents. We want to see whether it is effective during this distinct developmental window.” Unfortunately, many families in need of CBT face barriers, including limited availability of services and geographic constraints. One way to improve access is digital interventions. Silverman and her team are developing an evidence-based digitized intervention program for parents that they can access directly from their computer or smart phone. “The work we’re doing will be one of the very few parent interventions that is digitized and importantly tested for effectiveness,” she says. Creating interventions for anxiety-related challenges Silverman and Lebowitz recently received a generous gift to develop and test other interventions that help parents reduce other child anxiety-related behavioral and emotional difficulties, such as restrictive eating and unexplained somatic symptoms. One of these projects in particular focuses on understanding the risks of social media and its potential benefits, including offering a sense of connection. “A lot of research has focused on the idea that social media is harmful and the less of it the better,” says Lebowitz. “But we actually see is that this is not quite right—there are negatives, but there are also positives. So, we’re trying to get a little bit more nuanced of a picture.” The team is working with teens with social anxiety and their parents over an extended period to better understand their social media habits and how their anxiety levels affect engagement with different platforms. The teens will answer questions sent to an app on their phones about mood and social media usage in an effort to capture emotional responses as they unfold. “We hope to develop interventions that can help make the best of social media while protecting against the more problematic effects,” Lebowitz says. The brain’s role in anxiety Researchers are also testing therapies to address anxiety at the neurological and molecular levels. In collaboration with Dylan Gee, PhD, professor of psychology in Yale's Faculty of Arts and Sciences, and Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience at Yale School of Medicine, Lebowitz and Silverman are using brain imaging to identify changes in a child’s brain before and after parents enroll in SPACE. In one study, children viewed anxiety-inducing images while undergoing magnetic resonance imaging (MRI); the researchers conducted scans with and without the children’s parents nearby. Before SPACE, children’s brains were better able to activate the regulatory circuitry needed to turn off an anxious response when their parents were nearby. But after SPACE, children could activate this circuitry even without the parent around. “As parents work on gradually reducing some of their accommodations, you can see a child get better at regulating their own fear system in the brain,” Lebowitz says. “It’s remarkable.” Research into the molecular underpinnings of anxiety can also inform new childhood anxiety treatments. In a recent study, Lebowitz, Silverman, and Flora Vaccarino, MD, Harris Professor in the Child Study Center, discovered that a protein known as fibroblast growth factor 2 (FGF2) could be protective from the toxic effects of stress. FGF2 levels in children and their parents were linked to the children’s risk of developing anxiety and depression, the study showed. The findings could help explain why some children who are exposed to early life trauma such as poverty or abuse are more prone to developing mental health disorders. And FGF2 could be a target for treatment. “This is very novel because it starts to give a clue to what is the molecular chain that connects those lived experiences to the actual psychological outcomes,” Lebowitz says. New ways to study and treat childhood anxiety Michael Crowley, PhD, associate professor in the Child Study Center, collaborates with Silverman and Lebowitz to study the role that attention plays in development and maintenance of childhood anxiety. There is a large body of research that shows that anxious children, like anxious adults, are prone to focus on threatening stimuli such as angry faces compared with neutral faces. This has led to innovative interventions that involve attention retraining. The idea is that if experts train children to look away from threatening stimuli, it may reduce their anxiety—especially children with social anxiety who are most prone to attend to threats. The researchers have just completed a clinical trial for attention retraining with 10- to 14-year-olds with social anxiety disorders and are currently analyzing the findings. Besides this innovative attention retraining research, as Crowly notes, “I like to design tasks that are engaging to kids,” Crowley says. “My goal is to assess something without the kids knowing what we are assessing.” With this goal in mind, Crowley has created a virtual game, named Boom, to study threat processing in children with anxiety disorders. The game is similar to that of hot potato—the child and three digital players take turns virtually passing a ball to each other’s gloves. At some point, the ball turns into a bomb, and as the bomb lands in each player’s glove, the outline of the glove turns yellow. The goal is to avoid having the bomb go off in your glove. What isn’t obvious is that the game is designed to measure different types of threatening stimuli, both ambiguous and direct. In the game, the direct threat occurs as the bomb is traveling towards your glove. The ambiguous threat is the yellow outlined glove as it is unknown where the bomb will travel next. While children play the game, Crowley’s team measures their brain activity using electroencephalography (EEG). The researchers have discovered that in kids with anxiety, the brain reacts more strongly to ambiguous threats than it does in their peers, but less strongly to direct threats. They believe that the initial abnormally large brain response to not knowing where the bomb is going impairs the brain's ability to properly respond when the threat is actually traveling the child’s way. “The brains of children with anxiety are unable to differentiate between threats you need to do something about and those that are not your problem.” Michael Crowley, PhD, develops innovative games for studying anxiety in children and adolescents.Credit: Matt Bradbury Based on these insights, Crowley hopes to study whether interventions like attention training could restore appropriate threat processing. Crowley’s team is also working on a test called the Balloon Risk Avoidance Task, which evaluates risk-taking and avoidance behaviors. It features a digital balloon that is full of air and about to burst. Kids have six seconds to let air out of the balloon. The more air they let out, the less risk they face that the balloon will pop. But at the same time, the balloon becomes less valuable as it deflates. “The more air you keep in the balloon, the more points you get,” Crowley explains. So far, the researchers have found that when the balloons pop unexpectedly, teens with social anxiety show distinct brain responses. Studying these responses can help psychologists understand the underlying pathways driving the various manifestations of anxiety. The genetics of anxiety When Thomas Fernandez, MD, associate professor in the Child Study Center and of psychiatry, was still in training, there was a lot of excitement about understanding the genetics associated with autism spectrum disorder. Since then, scientists have identified around 250 genes associated with autism. The genetic contribution to anxiety disorders, on the other hand, has historically received less attention. Anxiety is less heritable than autism, but the genetic contribution for anxiety disorders that emerge in childhood may be higher than for anxiety disorders overall. While scientists estimate the heritability of anxiety disorders in general to be around 30% to 50%, some studies suggest higher heritability for certain childhood-onset anxiety presentations. “I saw firsthand how researchers in the field went about finding vulnerability genes for autism,” Fernandez says. “So, we’re using a very similar playbook for childhood anxiety.” “I saw firsthand how researchers in the field went about finding vulnerability genes for autism. So, we’re using a very similar playbook for childhood anxiety.” Thomas Fernandez, MD Associate Professor In the Child Study Center and in Psychiatry Now, Fernandez and Emily Olfson, MD, PhD, assistant professor in the Child Study Center, are studying children and their parents to identify genetic changes that are present in the child but not the parents, known as “de novo mutations.” “All of us have some de novo mutations—maybe about 50 to 100 sprinkled throughout the genome,” Olfson says. “But when they occur within the coding regions of genes, they can be really disruptive.” Previous research shows that people with autism have higher rates of damaging de novo mutations than the general population. In 2022, Olfson, Lebowitz, Silverman, and Fernandez published a study on 68 children and their families that found that children with anxiety had similarly high levels of these mutations. Studying de novo mutations can help point the researchers to where they should be looking for genes associated with anxiety. “The end game is using the genes to steer us toward the right part of biology that we can then target to come up with better treatments,” Fernandez says. Building on those findings, the team is now studying more families to better understand how these de novo mutations, along with other genetic and environmental factors, shape pediatric anxiety disorders. They recently received a National Institutes of Health grant to enroll 750 new families over the next five years. Olfson is the principal investigator, with co-investigators Lebowitz, Fernandez, Silverman, and Shuangge Steven Ma, PhD, department chair and professor of biostatistics at Yale School of Public Health. Neurodevelopment, Risk Genes, and Mental Health Conditions - The Olfson Lab Joel Gelernter, MD, Foundations Fund Professor of Psychiatry, is interested in how different anxiety disorders differ genomically. “We are studying social phobia, panic disorder, and generalized anxiety disorder, working to understand why people differ in their risk to these specific anxiety disorders and evaluating various risk factors,” he says. Gelernter was recently involved in one of the largest studies to date of the genomics underlying anxiety disorder. The study included around 122,000 people with anxiety disorders and around 730,000 without. It found that some genetic differences associated with anxiety were linked to signaling that helps reduce overactivity in the nervous system. Many anxiety medications available today work by targeting this process. “It’s nice when the biology that you get out of a large genome-wide study ratifies things that we already know because that can help increase confidence in further findings from the study,” Gelernter says. Uncovering the neurobiology of psychiatric disorders John Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and chair of the Department of Psychiatry, is interested in the neurobiology of psychiatric disorders, including post-traumatic stress disorder (PTSD), of which anxiety is a major symptom. In the late 1980s, Krystal’s team discovered that the drug yohimbine activated symptoms in patients with PTSD. “This was the first time we could link a specific biological mechanism to the symptoms of PTSD,” Krystal says. At the time, he adds, this finding was highly controversial. “A lot of people felt that PTSD was a purely psychological syndrome that didn’t have an underlying biology.” Since then, Krystal has dived deep into understanding the neurobiology of PTSD to learn how to better treat it. His team is evaluating the use of ketamine and psychedelics. These would be among the first treatments to be developed specifically for PTSD. They may also be applicable for other disorders including anxiety disorders, Krystal adds. An important gap in PTSD treatment is the absence of biological tests that inform how to best help patients manage their PTSD symptoms. A doctor doesn’t diagnose cancer based on how they feel. Rather, they use tests of the biology of the cancer to determine the best course of treatment. “And we can’t do that in any psychiatric disorder other than Alzheimer’s disease,” Krystal says. “But now we are building a foundation for this approach to the treatment of anxiety disorders for the first time.” Source: Yale School of Medicine
The challenge of measuring clinical value in mental health
Clients need assurances that high-cost medications flooding the system are aligned with the clinical support needed to improve mental health.
Doctors Should Keep an Eye on Your Mix of Medication. If They Don’t, You Should.
There’s a term for reducing unnecessary or harmful drugs: “deprescribing.” Especially as patients age, experts say, it’s important to regularly review the medications they’re taking.
MO nonprofit launches campaign focused on abortion options before vote
A new campaign helps Missourians navigate abortion access and medication options ahead of the November vote on Amendment 3.
TempraMed Announces VIVI Cap Smart Connectivity with Apple Health and Google Fit, Providing Better Health Outcomes and Data Tracking
VIVI Cap Smart transforms injectable medication protection into a connected health-data layer, enabling patients, caregivers and digital-health platforms to capture medication-use, temperature and adherence signals.Toronto, Ontario--(Newsfile Corp. - October 5, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology company transforming the storage, protection and management of temperature-sensitive medications, is pleased to
Fairfax Behavioral Health opens Lynnwood outpatient clinic
Branches Lynnwood will provide group therapy and medication management with a new focus on neurodivergent teens and adults.
Free Narcan training at Bismarck-Burleigh Public Health
Narcan is a medication that temporarily restores breathing during an overdose caused by fentanyl or other opioids.
GLP-1s Show Benefit For Kids With Type 2 Diabetes
By Ernie Mundell HealthDay ReporterFRIDAY, Oct 2, 2026 (HealthDay News) — A real-world study finds GLP-1 medications helped kids, teens and young adults with type 2 diabetes lose weight, as well as improve their blood pressure and blood sugar control. “Our results confirm that GLP-1 receptor ...
Patient Dies by Suicide After ‘Insurance Issue’ Delayed Medicine for Lung Disease Flare-Ups
Hours after experiencing a flare-up related to chronic obstructive pulmonary disease, Kenney Blewett of Kyle, Texas, died by suicide in June. A medication his doctor prescribed days earlier to ease his breathing problems hadn’t been filled due to an “insurance issue,” his pharmacy explained via email.
HOMETOWN HEALTH: Doctors more cautious prescribing anxiety medication, studies show
Prescriptions for the anxiety drug benzodiazepine are declining in the United States.
Clarest Health Launches Clarest Path, Bringing Clinically Trained AI to Medication Management at Scale
VIENNA, Va.--(BUSINESS WIRE)--Sep 30, 2026--
Abortion pills to be offered at California community college health centers under new law
Gov. Newsom has signed a law requiring most community colleges to offer abortion medication as of 2029. Public universities in California already do.
Abortion pills to be offered at California community college health centers under new law
This story was originally published by CalMatters. Sign up for their newsletters. Community colleges in California will be required to offer abortion medication through campus health centers starting in 2029, under a law signed by Gov. Gavin Newsom on Sunday. Through the Community College Student Right to Access Act, California will extend the reproductive health […]
Drugs are widely used to sedate dementia patients. Her sons wanted to keep her off them
Potent sedating medications are often used on agitated people with dementia in long-term care facilities despite federal efforts to discourage them. A clash over whether to drug a Michigan woman illuminates the wrenching decisions families and guardians face.
Atlantic Health Overlook Medical Center is 1st in NJ to use SetPoint System to treat Rheumatoid Arthritis
Atlantic Health Overlook Medical Center is the first hospital in New Jersey to use the SetPoint® System, a groundbreaking new device that uses neuromodulation to treat rheumatoid arthritis (RA), offering patients a non-medication option to treat the condition.
Where Healthcare Knows Your Name
See how two Health Mart pharmacies connect patients to medications, services and personalized support while helping keep care close to home.
A popular GLP-1 provider just made its weight loss medications cheaper
Mochi Health has lower starting prices for compounded semaglutide and tirzepatide, plus a new lab testing service designed to help patients monitor their health.
The Health Case For Investment In Clean Air In Africa
“From the very beginning, my life involved inhalers, medication, hospital visits, and many sleepless nights. One of my earliest memories having my first
Millions more people with overweight could benefit from GLP-1 drugs to protect heart health, study suggests
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, makes a case for extending the indication for GLP-1 receptor ...
Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest the popular joint supplement may intensify an abnormal sugar-tagging process in the Alzheimer’s brain, although researchers say clinical trials are needed to determine whether it actually causes harm.
Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest the popular joint supplement may intensify an abnormal sugar-tagging process in the Alzheimer’s brain, although researchers say clinical trials are needed to determine whether it actually causes harm.
Hauser Mental Health in Aviation Act Passes the Senate
The Senate passed the Hauser Mental Health in Aviation Act and a medication transparency bill for pilots and controllers. What they change and what comes next.
Hauser Mental Health in Aviation Act Passes the Senate
The Senate passed the Hauser Mental Health in Aviation Act and a medication transparency bill for pilots and controllers. What they change and what comes next.
Hauser Mental Health in Aviation Act Passes the Senate
The Senate passed the Hauser Mental Health in Aviation Act and a medication transparency bill for pilots and controllers. What they change and what comes next.
Why rheumatoid arthritis pain may persist even when inflammation is under control
Pain and fatigue in rheumatoid arthritis can persist even after inflammation improves, with depression, poor sleep, obesity, smoking, and chronic pain potentially helping sustain symptoms. Researchers say identifying these hidden drivers could prevent unnecessary medication changes and lead to more personalized treatment.
Got free health care? It's almost free at the Highlands County schools employee clinic
The new medical clinic should cost little to nothing for routine medical care and medications
6 Supplements You Probably Don’t Need to Take
The supplements you should take depend on your health, diet and medications. Here’s why some popular picks may not be necessary.
NBAA Applauds Approval of Bills to Support Mental Health, Clarify Aerospace Medicine Guidelines and More
NBAA welcomed Senate passage of the Mental Health in Aviation Act and the Aviation Medication Transparency Act, which will increase transparency around medication guidelines, expand access to mental health resources and reduce the stigma surrounding such needs, therefore safeguarding the careers of pilots, controllers and other aviation professionals.
Rising prescription and supplement use poses health risks for seniors
Older Americans are increasingly taking multiple prescription medications and dietary supplements. Although the prevalence of potentially major drug-drug interactions has declined slightly, more than 1 in 5 older adults are potentially at risk, according to a USC-led study published September 24 in JAMA.
FSU HEALTH COMMUNICATION EXPERT FINDS GLP-1 USERS FACE STIGMA WITHIN THEIR SOCIAL CIRCLES
Sept 24 2026 – People taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may face stigma from those closest to them, according to a new study by a Florida State University professor. Braidyn Lazenby, an assistant professor at FSU’s College of Communication & Information, led the study “‘They Call Us Cheaters:” Exploring Stigma […]
Westbrook Health Services Distributes Free Naloxone Across 8 Counties for Save a Life Day
Community health advocates across West Virginia joined a nationwide effort Thursday to place life-saving overdose reversal medication into the hands of the public during Save a Life Day.
FSU Health Communication expert finds GLP-1 users face stigma within their social circles
People taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may face stigma from those closest to them, according to a new study by a
Are your medical records updated? Probably so, thanks to Delaware Health Information Network
Truth be told, we all can be a little scatterbrained about our own healthcare. When a doctor asks about medications we once took or lab tests from long ago, we scratch our heads, make our best guesses, and wonder why someone doesn’t come up with a database that instantly keeps our health records up-to-date. As […]
Women's Health Care Affordability Challenges
As health care costs dominate the national political conversation, our 2026 KFF Women’s Health Survey shows the toll those costs are taking on women. Our new nationally representative survey of women and men ages 18–64 finds costs remain a major barrier for women, specifically — causing everything from delayed care to rationed medications to cuts in spending on basic needs.
Situation Report No.11: Earthquakes in Venezuela 2026 (M7.2 and M7.5)
Nearly three months after the 24 June 2026 earthquakes in Venezuela, the response has moved into early recovery while sustaining essential emergency operations. Efforts now center on maintaining continuity of care across mental health, sexual and reproductive health, maternal and neonatal care, NCDs, and rehabilitation, alongside restoring affected facilities, supporting transitional camps, and strengthening Health Cluster coordination as Emergency Medical Teams and international partners withdraw. Health system recovery is advancing, with 16 ASICs and 356 health facilities assessed (61% operational) and rehabilitation progressing under CERF, CFE and US funding, while fluctuating electricity, medication refrigeration and emergency-generator gaps continue to challenge the safe continuity of essential health services. Public health surveillance and prevention remain active, with 47,145 cumulative vaccine doses administered and 556 health professionals trained, while intensified surveillance in La Guaira and Miranda and mounting environmental risks from tropical rains and heatwaves continue to require sustained vector-control and water/sanitation action. Contraception remains the most consistent unmet need across assessed shelters, particularly among adolescents and young women, while mental health needs continue to rise across the transitional camps amid limited supplies and specialized personnel. PAHO/WHO continues to support the response with critically needed medical supplies and medicines, having shipped 46.6 metric tons to Venezuela to date, benefiting 72 actors and reaching 117,714 people with treatment through PAHO and partner donations, while sustained technical and logistical support to the Ministry of Popular Power for Health (MPPS) has strengthened the national supply chain and ensured the continuity of health services through the coordination, reception, and mobilization of international donations of essential medical products.
Carrot Top Overdosed at His Las Vegas Home During Health Crisis
Carrot Top is suspected to have suffered a drug overdose on Friday, Sept 18, at his Las Vegas home after he attempted suicide. TMZ reported that the comedian overdosed on prescription medication befor...
Presley Gerber dies at 27 of suspected overdose, police say. What Cindy Crawford's son said about recovery, medication and feeling 'misunderstood.'
Gerber, the older brother of model and actor Kaia Gerber, had spoken publicly about his mental health and experiences with addiction.
Presley Gerber dies at 27. What Cindy Crawford's model son said about recovery, medication and feeling 'misunderstood.'
Gerber, the son of Cindy Crawford and Rande Gerber, had spoken publicly about his mental health and experiences with addiction.
Fitbit creators unveil screenless wearable to help track aging parents
The $300 Luffu Link wearable has location sharing, health sensing, a wau to ask for help, plus voice logging for medications, meals, mood and other reminders.
Fitbit creators unveil screenless wearable to help track aging parents
The $300 Luffu Link wearable has location sharing, health sensing, a wau to ask for help, plus voice logging for medications, meals, mood and other reminders.
Telehealth Companies Keep Exposing Their Customers' Medical Data. What Should They Do?
WASHINGTON (AP) — The appeal of telehealth is easy to explain: Instead of calling a doctor, booking an appointment and hoping to eventually get a prescription, you can log onto an app or website and get approved for a new medication within minutes. Since the COVID-19 pandemic, scores of online ...
Heavy caffeine users and deeper sleep; wonders of microscopic life; preparing for life after an Alzheimer’s diagnosis; plus other stories with Vanderbilt Health sources
Beth Malow, MD, Professor of Neurology and Pediatrics in the Vanderbilt Sleep Division, was quoted in Women’s Health about a surprising study from the Journal of Psychopharmacology indicating that heavy caffeine users get deeper non-rapid-eye-movement sleep, even while sleeping less time. The New York Times quoted Dylan Burnette, PhD, Associate Professor of Cell and Developmental Biology, in a story (with videos) about the wonders of the microscopic life all around us. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Prevention (rabies vaccinations); Healthline (update on the Cyclospora outbreak); Prevention again (hundreds now sickened in measles outbreak); and AARP (“How do we know vaccines are safe?” video interview and transcript). Science posted a story about a new NIH research center on vaccine harms. The piece quotes Kathryn Edwards, MD, Professor of Pediatrics, Emerita. Lealani Mae Acosta, MD, MPH, Associate Professor of Neurology, was quoted in an Everyday Health story about how a person, after a diagnosis of Alzheimer’s disease, can enrich their life and prepare for the future. Amalia Peterson, MD, Assistant Professor of Neurology, was quoted by Everyday Health in a piece about common medications linked to lower dementia risk.
Oklahoma Health Care Authority improves access to medication to treat opioid use disorder
Oklahoma Medicaid recipients can now access a long-acting medication to treat opioid use disorder with fewer barriers.
Oklahoma Health Care Authority improves access to medication to treat opioid use disorder
Oklahoma Medicaid recipients can now access a long-acting medication to treat opioid use disorder with fewer barriers.
Keystone Behavioral Health Releases Substance Use Treatment FAQ for York County Patients and Families
York County provider addresses frequently asked questions about medication-assisted treatment, detox, levels of care and the cost of treatmentRock Hill, SC, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Keystone Behavioral Health, a York County provider of substance misuse prevention, intervention, treatment and recovery services, today released answers to frequently asked questions about substance use treatment for patients and families considering care. The FAQ addresses medication-assisted treatment, me
Karma TMS Marks 20,000 TMS Treatments, Transforming Mental Health Care Across the Coachella Valley and Riverside County
Palm Springs, California--(Newsfile Corp. - September 15, 2026) - Karma TMS PC, a leading provider of Transcranial Magnetic Stimulation (TMS) therapy in Southern California, today announced it has delivered more than 20,000 TMS treatments to patients across the Coachella Valley and Riverside County. The milestone reflects nearly a decade of growth for the practice. It underscores the rising demand for effective, non-invasive, medication-free options for treatment-resistant depression, anxiety,..
Survey: Adults With Multiple or Complex Health Conditions Face Significant Challenges with Health Costs and Commonly Struggle to Access Care
Adults with multiple or complex health conditions, who already face unique physical and mental challenges, commonly struggle to pay their medical bills and access needed care and medication—challenges that fall hardest on uninsured adults, according to a KFF survey of more than 25 thousand adults. “If the first obligation of a health care system is to take care of the sick, we are failing that test. Cost and access problems are hitting the chronically ill hard, and the chronically ill and uninsured especially hard,” said Dr. Drew Altman about the survey’s findings.
Health Care Access and Affordability for Adults with Multiple or Complex Health Conditions: A Snapshot of Patient Experiences
Significant shares of adults with multiple or complex health conditions, including cancer, lung disease, diabetes, cardiovascular disease, and mental health conditions say they struggle to pay their medical bills and access needed care and medication. These challenges fall hardest on uninsured adults who face greater costs and access challenges.
NIH awards multi-university team over $4M to improve women’s health
MSU researchers lead a $4.6 million NIH-funded project using AI and computational models to improve medication safety and precision care for women.
Heat hurting your mental and physical health: local psychiatrist says
A psychiatrist explains how extreme heat can worsen mood and depression and why some medications can increase the risk.
NIH awards multi-university team over $4M to improve women’s health
Backed by a new $4.6 million award from the National Institutes of Health, or NIH, Michigan State University researchers are launching a novel project to transform how medications are developed and prescribed for women. This is the first installment of an award worth up to $12.8 million over three years. Researchers from Rutgers, Emory, Tulane, University of Colorado Anschutz, University of Michigan and University of Utah are collaborating with the MSU team to accomplish this goal, which the lea
What are statins? And can healthy people use them to prevent heart disease and dementia?
New evidence shows more people might benefit from this cholesterol-lowering medication than we previously thought. But that doesn’t mean everyone should take one.
Bone Health Without the Hype
I am at the Australasian Menopause Society meeting and we had a fantastic lecture on Bone Health on Day 2, called, “Everything you need to know about bones - except the boring bits!” Spoiler alert, there were no boring bits. The lecture was given by Dr. Amanda Beech, who is a senior staff specialist in Obstetric Medicine and Endocrinology at the Royal Hospital for Women, where she is director of the Bone Density Unit. I want to summarize my top 10 take-aways for you. Share Osteoporosis is a disease of low bone mass, disruption of bone microarchitecture, and fragility of the skeleton. It is a silent disease…until someone develops a fracture. The diagnosis of osteoporosis is based on either fragility/minimal trauma fractures or a T-score of less than -2.5 on a DXA (Dual-Energy X-ray Absorptiometry) or bone scan. It is important to recognize that about 50% of minimal trauma fractures occur when women have low bone mass (often referred to as osteopenia), but not osteoporosis. This tells us that bone strength is more complicated than a number on a DXA report. I am going to add a little here that wasn’t in the talk (one can only include so much in 25 minutes), as many women might read the above paragraph and think, “Shouldn’t we be treating everyone with low bone mass if this is when 50% of the fractures occur?” Many fractures happen for women with low bone mass because there are so many women with low bone mass –it is a statement about the population on a whole, not about the fracture risk of low bone mass. For you as an individual, bone density is only one component of fracture risk and many women with lower bone mass will not have a significantly elevated fracture risk. This is why individualized risk assessment matters. Subscribe We build bone in our teens and twenties, and by the time we are about thirty we have reached peak bone mass. This is why, when we discuss risk factors for osteoporosis, it is important to consider factors that might have affected us in our teens and twenties when we were actively building bone, such as nutritional restriction/energy imbalance. It is important to ask women about a history of eating disorders, and for those with such a history, getting a bone scan in perimenopause or at age 50 is likely warranted. (This image below isn’t from the talk, but is similar to one that was). Bone mass is relatively stable until about two years before the final menstrual period, and perimenopause marks a time of rapid bone loss for women. Using urinary markers of bone loss we know that the time of significantly accelerated bone loss starts about 1 year before the final period and ends about 2 years after the final period. The Study of Women’s Health Across the Nation (SWAN) shows that over the menopause transition women lose an average of 10.6% of the bone at their lumbar spine and 9.1% at the femoral neck While this wasn’t covered in the lecture, I want to add that the rapid bone loss during perimenopause is clearly related to more than estradiol, because during this time estradiol levels can be erratic and not uniformly low. Bone loss during perimenopause is likely a multi-hormone event. For example, rising FSH (follicle stimulating hormone) tracks with bone loss better than estradiol, and there is evidence that FSH may act directly on bone. While decreased estrogen matters, there is clearly more going on. FSH and bone is an active area of research. Subscribe Screening for osteoporosis was recommended fairly broadly before age 65, and was taken from the “Practitioner’s Toolkit for Managing Menopause,” from Monash University. Here is a screenshot from the toolkit that was used as a slide: I am going to add a little bit more about body weight here for clarification. Low body mass (typically 152.1 lb): 0 points (risk neutral) 60–69 kg (132.3–152.1 lb): 3 points (adds some risk)
Meant Health Expands Telehealth Access to FDA-Approved GLP-1 Prescriptions, Including Ozempic®
Meant Health, a digital health platform that connects patients with licensed clinicians for evaluation, prescription and ongoing care coaching, announced today that it is expanding telehealth access to FDA-approved GLP-1 medications. The move is meant to shorten the distance between someone wondering whether a treatment might be right for them and an actual conversation with a U.S.-licensed clinician who could review their history and make that call.
Your next prescription could be treating a side effect from the last one
A major Ontario study found 24 common medication chains in which one drug’s side effects can be mistaken for a new medical problem, leading to another prescription. Researchers say closer medication reviews, pharmacist involvement, and automated alerts could help prevent these potentially harmful prescribing cascades.
Chimp convalescence, ant amputation: the wild world of animal doctors
When people are sick, we seek out medications and treatments to help heal. For a long time, scientists thought that was a uniquely human ability. But it turns out, many other animals do a version of it too! And since the late 1980s, western researchers have been trying to get a peek behind the curtain. And aside from just cataloguing all the cool examples just to know, there’s a real hope that studying animals’ medical cabinets may be the most promising way to expand our own. We get into the weeds with freelance science journalist Mandy Nguyen.Interested in more animal stories? Email us your ideas and questions to explore at shortwave@npr.org. They may become a future episode!Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org.
Genetic testing helps guide mental health medication choices
Genetic testing helps guide mental health medication choices
Williamson County moves forward with plans to sell health system to Ascension St. Thomas
After a medication error at Ascension St. Thomas Midtown left at least one woman paralyzed and put the hospital’s Medicare funding in jeopardy, some residents and county commissioners raised concerns about the sale.
Williamson County moves forward with plans to sell health system to Ascension St. Thomas
After a medication error at Ascension St. Thomas Midtown left at least one woman paralyzed and put the hospital’s Medicare funding in jeopardy, some residents and county commissioners raised concerns about the sale.
Williamson County moves forward with plans to sell health system to Ascension St. Thomas
After a medication error at Ascension St. Thomas Midtown left at least one woman paralyzed and put the hospital’s Medicare funding in jeopardy, some residents and county commissioners raised concerns about the sale.
Williamson County moves forward with plans to sell health system to Ascension St. Thomas
After a medication error at Ascension St. Thomas Midtown left at least one woman paralyzed and put the hospital’s Medicare funding in jeopardy, some residents and county commissioners raised concerns about the sale.
Williamson County moves forward with plans to sell health system to Ascension St. Thomas
After a medication error at Ascension St. Thomas Midtown left at least one woman paralyzed and put the hospital’s Medicare funding in jeopardy, some residents and county commissioners raised concerns about the sale.
The Case for a Psychiatric Deprescribing Clinic
Psychiatric medication prescribing practices have come under scrutiny since the Trump administration announced its plan to crack
The Case for a Psychiatric Deprescribing Clinic
Psychiatric medication prescribing practices have come under scrutiny since the Trump administration announced its plan to crack